Efficacy and Safety of DLBS1033 in Subjects With Type 2 Diabetes Mellitus

NCT01865474 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: DLBS1033
DRUG: placebo tablet of DLBS1033

Sponsor

Dexa Medica Group